These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10856736)

  • 41. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.
    DiBianco R; Shabetai R; Kostuk W; Moran J; Schlant RC; Wright R
    N Engl J Med; 1989 Mar; 320(11):677-83. PubMed ID: 2646536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [CHARM study--new strategy for the treatment of heart failure].
    Hasegawa H; Komuro I
    Nihon Rinsho; 2004 May; 62(5):995-1002. PubMed ID: 15148833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.
    Zampino M; O'Connor CM; Gattis WA; Adams KF; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S62-6. PubMed ID: 12594456
    [No Abstract]   [Full Text] [Related]  

  • 45. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
    Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
    Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent advances in the drug treatment of heart failure.
    McAlister FA; Teo KK
    Postgrad Med J; 1998 Nov; 74(877):658-61. PubMed ID: 10197196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine.
    Sami F; Acharya P; Noonan G; Maurides S; Al-Masry AA; Bajwa S; Parimi N; Boda I; Tran C; Goyal A; Mastoris I; Dalia T; Sauer A; Bakel AV; Shah Z
    J Card Fail; 2022 Dec; 28(12):1683-1691. PubMed ID: 36122816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.
    Levy E; Levy P
    Pharmacoeconomics; 2002; 20(14):963-77. PubMed ID: 12403637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
    Karlsberg RP; DeWood MA; DeMaria AN; Berk MR; Lasher KP
    Clin Cardiol; 1996 Jan; 19(1):21-30. PubMed ID: 8903534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of captopril versus milrinone therapy in modulating the adrenergic nervous system response to exercise in congestive heart failure.
    Corbalán R; Jalil J; Chamorro G; Casanegra P; Valenzuela P
    Am J Cardiol; 1990 Mar; 65(9):644-9. PubMed ID: 2178384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Response to milrinone treatment in patients with chronic congestive heart failure].
    Zeng H; Wen S; Huang D; Liu X; Fang Y
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):246-7, 259. PubMed ID: 12515150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.
    Krum H; Haas SJ; Eichhorn E; Ghali J; Gilbert E; Lechat P; Packer M; Roecker E; Verkenne P; Wedel H; Wikstrand J
    Eur Heart J; 2005 Oct; 26(20):2154-8. PubMed ID: 16014644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical trials on heart failure].
    Cosín Aguilar J; Hernándiz Martínez A
    Rev Esp Cardiol; 2001; 54 Suppl 1():22-31. PubMed ID: 11535185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis.
    Thackray S; Easthaugh J; Freemantle N; Cleland JG
    Eur J Heart Fail; 2002 Aug; 4(4):515-29. PubMed ID: 12167393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of nonglycosidic inotropic agents: indications, ethics, and limitations.
    Chatterjee K; De Marco T
    Med Clin North Am; 2003 Mar; 87(2):391-418. PubMed ID: 12693731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel Nebulized Milrinone Formulation for the Treatment of Acute Heart Failure Requiring Inotropic Therapy: A Phase 1 Study.
    Cox ZL; Dalia T; Goyal A; Fritzlen J; Gupta B; Shah Z; Sauer AJ; Haglund NA
    J Card Fail; 2024 Feb; 30(2):329-336. PubMed ID: 37871843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
    Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
    Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study).
    Echemann M; Alla F; Briançon S; Juillière Y; Virion JM; Mertès PM; Villemot JP; Zannad F; Aliot E; Breton Ch; KhalifE K; Neimann JL; Allam S; Admant P; Baille N; Bellanger P; D'Hôtel R; Dambrine P; Dodet JF; Graille M; Kessler M; Rebeix G; Royer ; Saulnier JP; Thisse JY; Trutt B; Vidal P; Vuillemin MCh; Delahaye ; Ducimetière P; Fagnani F; Guize L;
    Eur J Heart Fail; 2002 Oct; 4(5):647-54. PubMed ID: 12413509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.